Use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the upper urinary tract

被引：5
作者：
Gustin, P. [1 ]
Yossi, S. [1 ]
Lafont, M. [1 ]
Peyraga, G. [1 ]
Tremolieres, P. [1 ]
Rousseau, D. [1 ]
Cellier, P. [1 ]
Paumier, A. [1 ]
Martin, F. [2 ]
Chapet, O. [3 ]
Mesgouez-Nebout, N. [1 ]
机构：
[1] Inst Cancerol Ouest, Dept Radiotherapie, F-49000 Angers, France
[2] CHU Angers, Serv Urol, F-49933 Angers 9, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Radiotherapie, F-69495 Pierre Benite, France
来源：
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 02期
关键词：
Urothelial carcinoma; Radiotherapy; Chemotherapy; Adjuvant treatment; Upper urinary tract; TRANSITIONAL-CELL-CARCINOMA; RENAL PELVIS; PROGNOSTIC-FACTORS; RADICAL NEPHROURETERECTOMY; ADJUVANT RADIOTHERAPY; NEOADJUVANT CHEMOTHERAPY; URETER; SURVIVAL; CANCER; RECURRENCE;
D O I：
10.1016/j.canrad.2014.11.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Urothelial carcinomas of the upper urinary tract are rare entities. Surgery remains the mainstay of the management. The use of others therapeutic modalities is not clearly defined yet. However, the frequency of local recurrence and locoregional encourage us to evaluate the indication of adjuvant therapies. We conducted a synthesis of key data in the literature on the use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the renal pelvis and ureter. A literature search on PubMed was performed using the following keywords (MeSH) "urothelial carcinoma", "upper urinary tract", "radiation", "chemotherapy", and adjuvant. (C) 2015 Published by Elsevier Masson SAS on behalf of the Societe francaise de radiotherapie oncologique (SFRO).
引用
收藏
页码：120 / 126
页数：7
相关论文
共 42 条
[1]   The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC) [J].
Audenet, Francois ;
Yates, David R. ;
Cussenot, Olivier ;
Roupret, Morgan .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (04) :407-413
[2]   EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].
Babjuk, Marko ;
Oosterlinck, Willem ;
Sylvester, Richard ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou-Redorta, Juan .
EUROPEAN UROLOGY, 2008, 54 (02) :303-314
[3]   TIME TO DEFINE AN INTERNATIONAL STANDARD OF POSTOPERATIVE CARE FOR RESECTED UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA (TCC) - OPENING OF THE PERI-OPERATIVE CHEMOTHERAPY VERSUS SURVEILLANCE IN UPPER TRACT UROTHELIAL CANCER (POUT) TRIAL [J].
Birtle, Alison J. ;
Lewis, Rebecca ;
Johnson, Mark ;
Hall, Emma .
BJU INTERNATIONAL, 2012, 110 (07) :919-921
[4]   THE POSTOPERATIVE IRRADIATION OF TRANSITIONAL CELL-CARCINOMA OF THE RENAL PELVIS AND URETER [J].
BROOKLAND, RK ;
RICHTER, MP .
JOURNAL OF UROLOGY, 1985, 133 (06) :952-955
[5]  
Catton C N, 1996, Urol Oncol, V2, P171, DOI 10.1016/S1078-1439(96)00095-6
[6]   Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse [J].
Chen, Bing ;
Zeng, Zhao-Chong ;
Wang, Guo-Min ;
Zhang, Li ;
Lin, Zong-Ming ;
Sun, Li-An ;
Zhu, Tong-Yu ;
Wu, Li-Li ;
Zhang, Jian-Ying ;
Ji, Yuan .
BMC CANCER, 2011, 11
[7]   Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract [J].
Colin, Pierre ;
Koenig, Philippe ;
Ouzzane, Adil ;
Berthon, Nicolas ;
Villers, Arnauld ;
Biserte, Jacques ;
Roupret, Morgan .
BJU INTERNATIONAL, 2009, 104 (10) :1436-1440
[8]   ADJUVANT RADIOTHERAPY IN HIGH STAGE TRANSITIONAL CELL-CARCINOMA OF THE RENAL PELVIS AND URETER [J].
COZAD, SC ;
SMALLEY, SR ;
AUSTENFELD, M ;
NOBLE, M ;
JENNINGS, S ;
REYMOND, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (04) :743-745
[9]   Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter [J].
Czito, B ;
Zietman, A ;
Kaufman, D ;
Skowronski, U ;
Shipley, W .
JOURNAL OF UROLOGY, 2004, 172 (04) :1271-1275
[10]  
Fan Kang-Hsing, 2012, Chang Gung Med J, V35, P247
12345